前列腺癌患者皮肤纤维瘤显示68Ga-PSMA摄取
一名71岁前列腺癌患者在PSA升高后行68Ga-PSMA PET/CT再分期,检出局灶性PSMA摄取的皮下病变,切除后组织病理诊断为皮肤纤维瘤,提示皮肤纤维瘤可表达PSMA并在PET/CT上表现为摄取。
要点
- 68Ga-PSMA PET/CT可用于确定前列腺癌范围。
- 多种其他肿瘤也可能表达PSMA并在PET/CT上显示摄取。
- 皮肤纤维瘤可表现为局灶性PSMA摄取,需组织病理确诊。
核心结论
- 前列腺癌患者皮下病变显示局灶性68Ga-PSMA摄取,切除后组织病理诊断为皮肤纤维瘤。
研究设计与样本
- 病例报告:一名71岁前列腺癌患者因前列腺特异性抗原水平升高行68Ga-PSMA PET/CT再分期。
主要发现
- 68Ga-PSMA PET/CT检出显示局灶性PSMA摄取的皮下病变,其中一处被切除。
- 切除病变的组织病理学诊断为皮肤纤维瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen (PSMA) is a typ. 2 transmembrane protein that is highly expressed in prostate cancer cells. Ga-PSMA PET/CT imaging is a modality used to determine the extent of prostate cancer. Various other neoplasias may also express PSMA, which appears as Ga-PSMA uptake in PET/CT imaging. A 71-year-old man with prostate cancer underwent Ga-PSMA PET/CT imaging for restaging after having an elevated prostate-specific antigen level. Subcutaneous lesions showing focal PSMA uptake were detected, one of which was excised. The histopathologic diagnosis was dermatofibroma.
引用
- Aydin F, Akçal A, Ünal B, et al. 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer. Clin Nucl Med. 2017. PMID: 28240656. doi:10.1097/RLU.0000000000001591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。